Publications
Selected Publications
1. Mathew S, Tustison K, Sugatani T, Chaudhary LR, Rifas L, Hruska KA: The mechanism of phosphorus as a cardiovascular risk factor in CKD J Am Soc Neph 2008; 19: 1092-1105
2. Mathew S, Lund R, Chaudhary L, Geurs T, Hruska KA: Vitamin D receptor activators can protect against vascular calcification J Am Soc Neph 2008; 19: 1509-1519
3. Hruska KA, Mathew S, Lund R, Qiu P and Pratt R: Hyperphosphatemia of chronic kidney disease Kid Int 2008; 74: 148-157
4. Mathew S, Lund R, Strebeck F, Tustison K, Geurs T, Hruska K: Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Neph 2007; 18: 122-130.
5. De Petris L, Hruska K, Chiechio S, Liapis H: Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrology Dialysis Transplantation 2007; 22: 3442-3450
6. Sugatani T, Hruska KA: Akt1/Akt2 and mammalian target of Rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors J Biol Chem 2005; 280: 3583-3589
7. Surendran K, Schiavi S, Hruska KA: Wnt-dependent B-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis J Am Soc Nephrol 2005; 16: 2373-2384
Selected Reviews
1. Hruska KA, Mathew S: The CKD-MBD Primer of Metabolic Bone Diseases and Disorders of Mineral Metabolism 2008 in press
2. Hendy GN, Hruska KA, Mathew S, Goltzman D: New insights into mineral and skeletal regulation by active forms of vitamin D Kidney Int 2006; 69: 218-223
3. Mathew S, Davies M, Lund R, Saab G, Hruska KA: The function and effect of bone morphogenetic protein-7 in kidney-bone and the bone-vascular links in chronic kidney disease Eur J Clin Invest 2006; 36: 43-50
4. Hruska KA, Mathew S, Saab G: Bone morphogenetic proteins in vascular calcification Circ Res 2005; 97: 105-114